views

Intestinal infections in entericdiseases can range from asymptomatic and mild to severe symptoms includingabdominal cramps, vomiting, nausea and anorexia. Severe cases and symptomsunder some cases may even lead to death as well due to heavy loss of fluids andessential nutrients from the body.
Statistics:
The global EntericDisease Testing Market is estimated to account for US$ 3,732.7 Mn in termsof value by the end of 2020.
Global Enteric Disease TestingMarket: Drivers
High incidence of typhoid feveris expected to propel growth of the global enteric disease testing market overthe forecast period. For instance, according to the study, ‘The global burdenof typhoid and paratyphoid fevers: a systematic analysis for the Global Burdenof Disease Study 2017’, published in February 2019, globally, 14·3 millioncases of typhoid and paratyphoid fevers occurred in 2017.
Global Enteric Disease TestingMarket: Opportunities
R&D of new approaches isexpected to offer lucrative growth opportunities for players in the globalenteric disease testing market. For instance, in August 2020, researchers atPurdue University, U.S., reported development of a new 3D-printed capsule thatallows sampling of gut bacteria for further analysis and possibleidentification of disease.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1164
Global Enteric Disease TestingMarket: Restraints
Low public heath expenditure,especially in emerging economies, is expected to hinder growth of the global entericdisease testing market.
Key Takeaways:
The global enteric diseasetesting market was valued at US$ 3,643.4 Mn in 2019 and is forecast to reach avalue of US$ 4,432.7 Mn by 2027 at a CAGR of 2.5% between 2020 and 2027. Highincidence of typhoid fever is expected to propel growth of the global entericdisease testing market over the forecast period.
Market Trend
R&D in enteric diseases isexpected to propel growth of the global enteric disease testing market. Forinstance, in June 2020, researchers from University of Texas SouthwesternMedical Center, U.S., reported that l-arginine sensing regulates virulence geneexpression and disease progression in enteric pathogens.
Moreover, adoption of satelliteobservations in disease models is also expected to aid in growth of the market.Researchers can use Earth observing satellites to track when and where certaindiseases will emerge and spread.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/enteric-disease-testing-market-1164
Global Enteric Disease Testing Market:Competitive Landscape
Major players operating in theglobal enteric disease testing market include, Alere, Inc., Becton Dickinson& Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept,DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech.
Global Enteric Disease TestingMarket: Key Developments
Major players in the globalenteric disease testing market are focused on approval and launch of newproducts to expand their product portfolio. For instance, in December 2018,Becton, Dickinson and Company received U.S. Food and Drug Administration (FDA) 510(k)clearance for its BD Max enteric viral panel, a molecular diagnostic test forthe detection and differentiation of pathogens that cause viralgastroenteritis.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1164
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737